Total Payments
$628,583
2024 Payments
$36,431
Companies
47
Transactions
1,201
Medicare Patients
2,531
Medicare Billing
$337,592
Payment Breakdown by Category
Other$280,210 (44.6%)
Consulting$241,476 (38.4%)
Travel$61,367 (9.8%)
Food & Beverage$35,836 (5.7%)
Education$9,693 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $241,476 | 186 | 38.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $180,278 | 63 | 28.7% |
| Honoraria | $98,611 | 44 | 15.7% |
| Travel and Lodging | $61,367 | 173 | 9.8% |
| Food and Beverage | $35,836 | 721 | 5.7% |
| Education | $9,693 | 11 | 1.5% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $1,281 | 2 | 0.2% |
| Entertainment | $41.42 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $202,045 | 504 | $0 (2024) |
| Medtronic USA, Inc. | $106,025 | 96 | $0 (2020) |
| Averitas Pharma Inc. | $72,074 | 78 | $0 (2024) |
| GRT US Holding, Inc. | $65,518 | 81 | $0 (2022) |
| SI-BONE, INC. | $60,520 | 78 | $0 (2023) |
| Jazz Pharmaceuticals Inc. | $34,631 | 36 | $0 (2018) |
| Nevro Corp. | $32,837 | 58 | $0 (2024) |
| Medtronic, Inc. | $24,388 | 40 | $0 (2024) |
| TerSera Therapeutics LLC | $11,381 | 29 | $0 (2023) |
| Zimmer Biomet Holdings, Inc. | $9,853 | 14 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $36,431 | 105 | Averitas Pharma Inc. ($26,147) |
| 2023 | $64,896 | 158 | Averitas Pharma Inc. ($45,927) |
| 2022 | $109,151 | 246 | GRT US Holding, Inc. ($64,773) |
| 2021 | $46,017 | 137 | SI-BONE, INC. ($20,021) |
| 2020 | $28,830 | 86 | Abbott Laboratories ($11,530) |
| 2019 | $91,027 | 117 | Abbott Laboratories ($42,867) |
| 2018 | $151,017 | 192 | Abbott Laboratories ($59,826) |
| 2017 | $101,214 | 160 | Abbott Laboratories ($44,903) |
All Payment Transactions
1,201 individual payment records from CMS Open Payments — Page 1 of 49
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $46.38 | General |
| Category: Neuromodulation | ||||||
| 12/17/2024 | Fidia Pharma USA Inc. | HYMOVIS (Device), HYALGAN, TRILURON | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: OSTEOARTHRITIS | ||||||
| 12/10/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $33.76 | General |
| Category: Not Applicable | ||||||
| 11/13/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Honoraria | Cash or cash equivalent | $952.50 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/05/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $84.27 | General |
| Category: Neuromodulation | ||||||
| 11/05/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $25.11 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/04/2024 | MML US, Inc. | ReActiv8 (Device) | Food and Beverage | Cash or cash equivalent | $15.02 | General |
| Category: Pain Management | ||||||
| 10/23/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Honoraria | Cash or cash equivalent | $2,500.00 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/23/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $41.26 | General |
| Category: Neuromodulation | ||||||
| 10/23/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $30.26 | General |
| Category: Neuromodulation | ||||||
| 10/23/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/23/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Neuromodulation | ||||||
| 10/15/2024 | MML US, Inc. | ReActiv8 (Device) | Food and Beverage | Cash or cash equivalent | $89.67 | General |
| Category: Pain Management | ||||||
| 10/08/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $32.17 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 09/05/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $148.31 | General |
| Category: Neuromodulation | ||||||
| 09/04/2024 | MML US, Inc. | ReActiv8 (Device) | Food and Beverage | Cash or cash equivalent | $4.86 | General |
| Category: Pain Management | ||||||
| 08/29/2024 | Abbott Laboratories | PROCLAIM (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,440.00 | General |
| Category: Neuromodulation | ||||||
| 08/22/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: Neuromodulation | ||||||
| 08/19/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $132.37 | General |
| Category: Not Applicable | ||||||
| 08/14/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Honoraria | Cash or cash equivalent | $2,500.00 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/14/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $952.50 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/14/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Travel and Lodging | Cash or cash equivalent | $207.70 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/08/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $127.46 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/07/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 08/06/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $83.93 | General |
| Category: Spinal Cord Neurostimulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 1,215 | 10,350 | $844,790 | $156,947 |
| 2022 | 24 | 759 | 1,020 | $633,900 | $122,083 |
| 2021 | 12 | 281 | 328 | $286,299 | $36,565 |
| 2020 | 10 | 276 | 894 | $70,945 | $21,998 |
Total Patients
2,531
Total Services
12,592
Medicare Billing
$337,592
Procedure Codes
81
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 172 | 242 | $134,940 | $26,777 | 19.8% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 60 | 61 | $86,240 | $13,971 | 16.2% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 72 | 118 | $66,960 | $12,651 | 18.9% |
| 0275T | Removal of bone from lower spine for decompression of nerve tissue using imaging guidance, accessed through the skin | Facility | 2023 | 13 | 13 | $45,500 | $10,485 | 23.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 68 | 68 | $39,440 | $8,542 | 21.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 77 | 77 | $30,030 | $7,081 | 23.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 78 | 89 | $28,480 | $6,729 | 23.6% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 27 | 66 | $28,380 | $6,707 | 23.6% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 64 | 103 | $34,200 | $6,301 | 18.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 60 | 65 | $29,250 | $6,109 | 20.9% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 31 | 31 | $18,600 | $6,038 | 32.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 28 | 70 | $26,220 | $5,129 | 19.6% |
| J7328 | Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | Office | 2023 | 11 | 8,736 | $87,360 | $4,309 | 4.9% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 55 | 60 | $22,000 | $4,209 | 19.1% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 34 | 49 | $18,560 | $3,879 | 20.9% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Facility | 2023 | 21 | 33 | $17,390 | $3,542 | 20.4% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Facility | 2023 | 34 | 40 | $14,800 | $3,501 | 23.7% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 16 | 17 | $19,500 | $3,385 | 17.4% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2023 | 56 | 69 | $12,420 | $2,988 | 24.1% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 25 | 29 | $9,860 | $2,250 | 22.8% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2023 | 42 | 84 | $17,640 | $2,198 | 12.5% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 32 | 32 | $6,080 | $1,897 | 31.2% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Facility | 2023 | 17 | 27 | $7,980 | $1,621 | 20.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Facility | 2023 | 25 | 33 | $7,040 | $1,483 | 21.1% |
| 20553 | Injection of trigger points, 3 or more muscles | Facility | 2023 | 21 | 36 | $5,400 | $1,265 | 23.4% |
About Dr. Yeshvant Navalgund, MD
Dr. Yeshvant Navalgund, MD is a Pain Medicine healthcare provider based in Greensburg, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1558354738.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Yeshvant Navalgund, MD has received a total of $628,583 in payments from pharmaceutical and medical device companies, with $36,431 received in 2024. These payments were reported across 1,201 transactions from 47 companies. The most common payment nature is "Consulting Fee" ($241,476).
As a Medicare-enrolled provider, Navalgund has provided services to 2,531 Medicare beneficiaries, totaling 12,592 services with total Medicare billing of $337,592. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Other Specialties Pain Medicine, Pain Medicine
- Location Greensburg, PA
- Active Since 08/24/2005
- Last Updated 11/14/2024
- Taxonomy Code 208VP0000X
- Entity Type Individual
- NPI Number 1558354738
Products in Payments
- QUTENZA (Drug) $72,074
- Qutenza (Drug) $65,518
- ADAPTIVESTIM (Device) $55,982
- Axium INS DRG IPG (Device) $54,729
- Prialt (Drug) $46,012
- Proclaim Family of SCS IPGs (Device) $36,436
- Senza Spinal Cord Stimulation System (Device) $31,350
- PROCLAIM (Device) $31,200
- IFUSE IMPLANT (Device) $30,401
- iFuse Implant (Device) $28,651
- SCS leads (Device) $19,592
- INTELLIS (Device) $16,425
- RESTORE (Device) $14,900
- Neuromodulation Dspsbls and Accs (Device) $13,166
- SCS IPGs (Device) $11,833
- INTELLIS ADAPTIVESTIM (Device) $10,309
- DRG leads (Device) $9,707
- KYPHON Balloon Kyphoplasty (Device) $8,806
- SYNCHROMED (Device) $7,334
- Prodigy Family of SCS IPGs (Device) $7,214
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.